Active Pharmaceutical Ingredient (Generic)

CRIZOTINIB

🩺 ANTINEOPLASTICS 💊 1 Marketed Brands
Clinical Profile:

*Anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer, ROS1-positive advanced non-small cell lung cancer:* Adult: 250 mg twice daily, consult product literature for information on dose adjustments.

Marketed Brands Containing CRIZOTINIB (1) Compare Brand Prices
Brand Name Manufacturer / Company Available Pack Sizes & Price Action
CRIZONIX 🏢 HIMMEL
Cap 250 mg 30: Rs.81797.00
Cap 250 mg 60: Rs.160322.00
View Details →